Is There A Connection Between Primary Hypophysitis and Celiac Disease?

Abstract

Aim To investigate the autoimmune and genetic relationship between primary hypophysitis (PH) and celiac disease (CD).

Methods The study was retrospective and patients with PH followed in our clinic between 2007 and 2022 were evaluated. Clinical, endocrinologic, pathologic, and radiologic findings and treatment modalities were assessed. Patients diagnosed with CD in the Gastroenterology outpatient clinic in 2020–2022 were included in the study as a control group. Information such as sociodemographic data, year of diagnosis, human leukocyte antigen (HLA) DQ2/8 information, CD-specific antibody levels, pathologic results of duodenal biopsy, treatment received, follow-up status, additional diseases, hormone use, and surgical history was obtained from patient records at PH.

In patients diagnosed with PH, a duodenal biopsy was obtained, and the tissue was examined for CD by experienced pathologists. Anti-pituitary antibody (APA) and anti-arginine-vasopressin (AAVP) antibody levels of individuals with PH and CD were measured.

Results The study included 19 patients with lymphocytic hypophysitis, 30 celiac patients, and 30 healthy controls. When patients diagnosed with lymphocytic hypophysitis were examined by duodenal biopsy, no evidence of CD was found in the pathologic findings. The detection rate of HLA-DQ2/8 was 80% in celiac patients and 42% in PH (p=0.044). (APA and AAVP antibodies associated with PH were tested in two separate groups of patients and in the control group. APA and anti-arginine vasopressin (AAVP) levels in PH, CD and healthy controls, respectively M [IQR]: 542 [178–607];164 [125–243]; 82 [74–107] ng/dL (p=0.001), 174 [52–218]; 60 [47–82]; 59 [48–76] ng/dL (p=0.008) were detected. The presence of an HLA-DQ2/8 haplotype correlates with posterior hypophysitis and panhypophysitis (r=0.598, p=0.04 and r=0.657, p=0.02, respectively).

Conclusion Although patients with PH were found to have significant levels of HLA-DQ2/8, no CD was found in the tissue. Higher levels of pituitary antibodies were detected in celiac patients compared with healthy controls, but no hypophysitis clinic was observed at follow-up. Although these findings suggest that the two diseases may share a common genetic and autoimmune basis, the development of the disease may be partially explained by exposure to environmental factors.

Key words

primary hypophysitis - celiac disease - autoimmunity

Publication History

Received: 15 July 2023
Received: 14 November 2023

Accepted: 17 November 2023

Accepted Manuscript online:
17 November 2023

Article published online:
18 January 2024

• References

• 1 Donegan D, Honegger J. Hypophysitis. Endocr Pract 2022; 28: 901-910 DOI: 10.1016/j.eprac.2022.06.009.
• 2 Langlois F, Varlamov EV, Fleseriu M. Hypophysitis, the growing spectrum of a rare pituitary disease. J Clin Endocrinol Metab 2022; 107: 10-28 DOI: 10.1210/clinem/dgab672.
• 3 Joshi MN, Whitelaw BC, Carroll PV. Mechanisms in endocrinology: Hypophysitis: Diagnosis and treatment. Eur J Endocrinol 2018; 179: R151-R163 DOI: 10.1530/EJE-17-0009.
• 4 Gubbi S, Hannah-Shmouni F, Verbalis JG. et al. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab 2019; 33: 101371 DOI: 10.1016/j.beem.2019.101371.
• 5 Yasuda Y, Iwama S, Kiyota A. et al. Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis. J Pathol 2018; 29 DOI: 10.1002/path.5046.
• 6 Kluczyński L, Gilis-Januszewska A, Rogoziński D. et al. Hypophysitis – new insights into diagnosis and treatment. Endokrynol Pol 2019; 70: 260-269 DOI: 10.5603/EP.a2019.0015.
• 7 Yuen KCJ, Popovic V, Trainer PJ. New causes of hypophysitis. Best Pract Res Clin Endocrinol Metab 2019; 33: 101276 DOI: 10.1016/j.beem.2019.04.010.
• 8 de Vries F, van Furth WR, Biermasz NR. et al. Hypophysitis: A comprehensive overview. Presse Med 2021; 50: 104076 DOI: 10.1016/j.lpm.2021.104076.
• 9 Chiloiro S, Capoluongo ED, Tartaglione T. et al. human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in Caucasian patients. Clin Endocrinol (Oxf) 2018; 88: 692-699 DOI: 10.1111/cen.13566.
• 10 Fleseriu M, Hashim IA, Karavitaki N. et al. Hormonal replacement in hypopituitarism in adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 3888-3921
• 11 Lury KM. Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 2005; 16: 301-306
• 12 Trajanoski D, Fidler SJ. HLA typing using bead-based methods. Methods Mol Biol 2012; 882: 47-65 DOI: 10.1007/978-1-61779-842-94.
• 13 Cesbron-Gautier A, Simon P, Achard L. et al. Luminex technology for HLA typing by PCR-SSO and identification of HLA antibody specificities. Ann Biol Clin (Paris) 2004; 62: 93-98
• 14 World Gastroenterology Organisation Global Guidelines, Celiac Disease. 2016. http://www.worldgastroenterology.org/guidelines/glob-al-guidelines/celiac-disease; Accessed May 14 2017
• 15 AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006; 131: 1977-1980
• 16 Özgenel SM, Temel T, Uskudar Teke H. et al. HLA -DQ2/DQ8 frequency in adult patients with celiac disease, their first-degree relatives, and normal population in Turkey. Turk J Gastroenterol 2019; 30: 321-325
• 17 Amereller F, Küppers AM, Schilbach K. et al. Clinical characteristics of primary hypophysitis - a single-centre series of 60 cases. Exp Clin Endocrinol Diabetes 2021; 129: 234-240 DOI: 10.1055/a-1163-7304.
• 18 Khare S, Jagtap VS, Budyal SR. et al. Primary (autoimmune) hypophysitis: A single centre experience. Pituitary 2015; 18: 16-22 DOI: 10.1007/s11102-013-0550-9.
• 19 Honegger J, Buchfelder M, Schlaffer S. et al. Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 2015; 100: 3460-3469
• 20 Karaca Z, Kelestimur F. The management of hypophysitis. Minerva Endocrinol 2016; 41: 390-399
• 21 Iwama S, Arima H. Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands. Endocr J 2020; 67: 1077-1083 DOI: 10.1507/endocrj. EJ20-0436.
• 22 Romano A, Rigante D, Cipolla C. Autoimmune phenomena involving the pituitary gland in children: New developing data about diagnosis and treatment. Autoimmun Rev 2019; 18: 102363 DOI: 10.1016/j.autrev.2019.102363.
• 23 Murai A, Shinojima N, Ikuta G. et al. Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody. Endocr J 2023; 70: 703-709 DOI: 10.1507/endocrj.EJ22-0637.
• 24 Chiloiro S, Giampietro A, Angelini F. et al. Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: A pilot study. Endocrine 2021; 73: 308-315 DOI: 10.1007/s12020-021-02612-5.
• 25 Kobayashi T, Iwama S, Sugiyama D. et al. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. J Immunother Cancer 2021; 9: e002493 DOI: 10.1136/jitc-2021-002493.